Francesca Barone
Chief Tech/Sci/R&D Officer at CANDEL THERAPEUTICS, INC.
Net worth: 44 918 $ as of 2024-03-30
Francesca Barone active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-10-31 | - |
Career history of Francesca Barone
Former positions of Francesca Barone
| Companies | Position | Start | End |
|---|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2019-04-30 | 2020-10-31 |
| University of Birmingham | Corporate Officer/Principal | 2009-12-31 | 2019-04-30 |
| Institute of Translational Medicine | Corporate Officer/Principal | - | - |
Training of Francesca Barone
| Sapienza University of Rome | Doctorate Degree |
| King's College London | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 3 |
| Italy | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
| Institute of Translational Medicine |
- Stock Market
- Insiders
- Francesca Barone
- Experience